SCHEMBL698745

SCHEMBL698745

Cc1c(C)c2c(C)c3c(C)c(N)oc3cc2oc1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH2 P05091 3/20 0.45
ALDH1A2 O94788 1/20 0.43
ALDH1B1 P30837 1/20 0.43
ALDH1A3 P47895 1/20 0.43
KDM4E B2RXH2 7/20 0.39
ALDH1A1 P00352 6/20 0.39
HSD17B10 Q99714 5/20 0.39
HPGD P15428 4/20 0.39
MAPK1 P28482 1/20 0.39
THRB P10828 1/20 0.37
HSD17B3 P37058 1/20 0.37
LMNA P02545 2/20 0.36
TSHR P16473 2/20 0.36
BRD4 O60885 1/20 0.35
MAPT P10636 2/20 0.34
GAA P10253 2/20 0.34
MEN1 O00255 1/20 0.34
GLA P06280 1/20 0.34
KMT2A Q03164 1/20 0.34
STS P08842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7124976 0.78 ALDH2 (0.35) ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E
SCHEMBL10548888 0.77 ALDH2 (0.45) ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E
SCHEMBL17525029 0.75 ALDH2 (0.59) ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E
SCHEMBL9277301 0.74 ALDH2 (0.63) ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E
SCHEMBL1319676 0.73 ALDH2 (0.53) ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E
SCHEMBL27907872 0.72 ALDH2 (0.47) ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E
SCHEMBL7598443 0.72 ALDH2 (0.44) ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E
SCHEMBL1002679 0.69 CYP3A4 (0.49) ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E
SCHEMBL10550597 0.68 ALDH2 (0.44) ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E
SCHEMBL5903908 0.68 ALDH2 (0.44) ALDH2ALDH1A2ALDH1B1ALDH1A3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014136115-A1 NON-SELFABSORBING LUMINESCENT SOLAR CONCENTRATOR YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2014-09-12 WO claimed
US-8409814-B2 Sensor proteins and assay methods Life Technologies Corporation (US) 2013-04-02 US claimed
US-20110111422-A1 SENSOR PROTEINS AND ASSAY METHODS Life Technologies Corporation (US) 2011-05-12 US claimed
US-7619059-B2 Bimolecular optical probes Life Technologies Corporation (US) 2009-11-17 US claimed
US-20080213811-A1 SENSOR PROTEINS AND ASSAY METHODS INVITROGEN CORPORATION (US) 2008-09-04 US claimed
EP-1671128-A2 MULTIPLEX BINDING AND ACTIVITY ASSAYS INVITROGEN CORPORATION (US) 2006-06-21 EP claimed
WO-2005026730-A2 MULTIPLEX BINDING AND ACTIVITY ASSAYS INVITROGEN CORPORATION (US) 2005-03-24 WO claimed
US-20050064485-A1 Multiplex binding and activity assays Life Technologies Corporation 2005-03-24 US claimed
EP-0719150-B1 CELLULAR VACCINE AND ITS USE FOR THE TREATMENT OF SOLID TUMOR MALIGNANCIES UNIV YALE (US) 2004-03-03 EP claimed
EP-0683671-B1 IMMUNE SYSTEM MODULATION USING PSORALENS ACTIVATED WITH VISIBLE LIGHT UNIV YALE (US) 2002-01-09 EP claimed
WO-1996000901-A1 LUMINESCENT LANTHANIDE CHELATES AND METHODS OF USE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-01-11 WO claimed
EP-0683671-A1 IMMUNE SYSTEM MODULATION USING PSORALENS ACTIVATED WITH VISIBLE LIGHT YALE UNIVERSITY (US) 1995-11-29 EP claimed
US-5462733-A Irradiating a suspension of cells with visible light in the presence of psoralen YALE UNIVERSITY (US) 1995-10-31 US claimed
EP-0668772-A1 SPECIFIC IMMUNE SYSTEM MODULATION YALE UNIVERSITY (US) 1995-08-30 EP claimed
WO-1995003814-A1 CELLULAR VACCINE AND METHODS OF USE FOR THE TREATMENT OF SOLID TUMOR MALIGNANCIES YALE UNIVERSITY (US) 1995-02-09 WO claimed
WO-1995000631-A1 SYSTEM FOR VIRAL INACTIVATION OF BLOOD NEW YORK BLOOD CENTER, INC. (US) 1995-01-05 WO claimed
WO-1994017812-A1 IMMUNE SYSTEM MODULATION USING PSORALENS ACTIVATED WITH VISIBLE LIGHT YALE UNIVERSITY (US) 1994-08-18 WO claimed
WO-1994011016-A1 SPECIFIC IMMUNE SYSTEM MODULATION YALE UNIVERSITY (US) 1994-05-26 WO claimed
US-4838852-A CONTACTING WITH ANTIGEN, WITHDRAWAL BLOOD, IRRADIATING, RETURNING TO PATIENT THERAKOS, INC. (US) 1989-06-13 US claimed
EP-0284409-A2 Active specific immune suppression THERAKOS, Inc. (US) 1988-09-28 EP claimed